LabNetwork reaches European customers through marketplace collaboration

By Maggie Lynch

- Last updated on GMT

(Image: Getty/BrianAJackson)
(Image: Getty/BrianAJackson)

Related tags Collaboration Chemical compound Preclinical contract research Preclinical services preclinical Wuxi apptec China

Chemspace and LabNetwork, both online marketplaces, are to collaborate to extend their global reach in the online marketplace.

Per the agreement, LabNetwork, a WuXi AppTec company based in China, will make its products available on Chemspace’s website while distribution and technical support for European customers will be provided by Chemspace, enabling LabNetwork’s marketplace to reach further.

WuXi’s LabNetwork was established​ in 2016 to provide pharmaceutical firms with a list of chemical suppliers to help drug manufacturers source more efficiently. LabNetwork also has four million commercially available discovery and research compounds.

US-based Chemspace’s free-of-charge database encompasses over 100m chemical building blocks, fragments and screening compounds all for purchase.

Yurii Moroz, CEO, Chemspace said in a statement, “The collaboration with LabNetwork will provide drug discovery scientists, medicinal chemists, and academic researchers access to a vast diversity of high-quality products. We see a lot of synergy in our companies combining forces both from a business perspective and also to improve availability of compounds to the research community.”

The online catalog provided through the online marketplace includes in-stock and make-on-demand molecules. According to the company, the marketplace has a range of filter options to increase searchability, including options to filter substructure, similarity, and text identifiers.

Moroz told us, that the collaboration will “increase availability of high-quality chemical building blocks and reagents available to Chemspace’s European customers.”

This is not the first collaboration​ for WuXi’s LabNetwork: In 2017 it entered a partnership with Reaxys to simplify customer purchasing decisions. 

Related news

Show more

Related products

Designing an Optimal APAC Clinical Supply Chain

Designing an Optimal APAC Clinical Supply Chain

Catalent | 08-Mar-2023 | Infographic

With clinical study activity increasing across the Asia-Pacific region, it is important for sponsors—both in APAC and globally—to understand the broader...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Thermo Fisher Scientific - Process Liquid Preparation Services | 21-Feb-2023 | Technical / White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Enhance your cGMP chemical supply chain

Enhance your cGMP chemical supply chain

Thermo Fisher Scientific – Production Chemicals and Services | 09-Feb-2023 | Technical / White Paper

Supply chain issues have real, quantifiable impacts on biomanufacturers. However, the right support can make a cGMP supply chain operate seamlessly. Thermo...

Related suppliers

Follow us


View more